SMMT vs. HIMS
SMMT (Summit Therapeutics Inc.) and HIMS (Hims & Hers Health, Inc.) are both stocks. Both are in the Healthcare sector — SMMT in Biotechnology, HIMS in Drug Manufacturers - Specialty & Generic. Over the past 5 years, SMMT returned 15.49%/yr vs 17.04%/yr for HIMS. At a 0.21 correlation, their price movements are largely independent.
Performance
SMMT vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMMT achieves a -19.90% return, which is significantly lower than HIMS's -17.40% return.
SMMT
- 1D
- 7.11%
- 1M
- -25.44%
- YTD
- -19.90%
- 6M
- -20.26%
- 1Y
- -30.51%
- 3Y*
- 93.96%
- 5Y*
- 15.49%
- 10Y*
- 5.31%
HIMS
- 1D
- -7.10%
- 1M
- 11.10%
- YTD
- -17.40%
- 6M
- -27.92%
- 1Y
- -53.07%
- 3Y*
- 43.69%
- 5Y*
- 17.04%
- 10Y*
- —
SMMT vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics Inc. | -19.90% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 11.14% |
HIMS Hims & Hers Health, Inc. | -17.40% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
Correlation
The correlation between SMMT and HIMS is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.21 |
Fundamentals
SMMT:
$10.86B
HIMS:
$6.12B
SMMT:
-$1.60
HIMS:
-$0.05
SMMT:
19.90
HIMS:
13.73
SMMT:
$0.00
HIMS:
$2.37B
SMMT:
-$83.36K
HIMS:
$1.70B
SMMT:
-$738.34M
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMMT vs. HIMS — Risk / Return Rank
SMMT
HIMS
SMMT vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMMT | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.15 | ||
| Sortino ratioReturn per unit of downside risk | +0.32 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 0.95 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | -0.55 | -0.68 | +0.13 |
| Martin ratioReturn relative to average drawdown | -0.87 | -1.10 | +0.23 |
Loading charts...
Drawdowns
SMMT vs. HIMS - Drawdown Comparison
The maximum SMMT drawdown since its inception was -95.75%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for SMMT and HIMS.
Loading charts...
Drawdown Indicators
| SMMT | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.75% | -87.29% | -8.46% |
Max Drawdown (1Y)Largest decline over 1 year | -55.49% | -78.06% | +22.57% |
Max Drawdown (3Y)Largest decline over 3 years | -64.44% | -78.88% | +14.44% |
Max Drawdown (5Y)Largest decline over 5 years | -91.78% | -78.88% | -12.90% |
Max Drawdown (10Y)Largest decline over 10 years | -95.75% | — | — |
Current DrawdownCurrent decline from peak | -61.83% | -60.98% | -0.85% |
Average DrawdownAverage peak-to-trough decline | -57.63% | -43.23% | -14.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.94% | 48.06% | -13.12% |
Volatility
SMMT vs. HIMS - Volatility Comparison
Summit Therapeutics Inc. (SMMT) has a higher volatility of 23.99% compared to Hims & Hers Health, Inc. (HIMS) at 21.36%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMMT | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.99% | 21.36% | +2.63% |
Volatility (6M)Calculated over the trailing 6-month period | 56.65% | 67.20% | -10.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.61% | 96.46% | -20.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 185.08% | 83.26% | +101.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 144.46% | 77.20% | +67.26% |
Dividends
SMMT vs. HIMS - Dividend Comparison
Neither SMMT nor HIMS has paid dividends to shareholders.
Financials
SMMT vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Summit Therapeutics Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SMMT and HIMS have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMMT has higher volatility (23.99%) compared to HIMS (21.36%). In terms of maximum drawdown, SMMT dropped -95.75% vs HIMS's -87.29%.
SMMT currently has the higher Sharpe Ratio (-0.41 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMMT and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer